Identification of amino acids in the glutamate receptor, GluR3, important for antibody-binding and receptor-specific activation - PubMed
- ️Wed Jan 01 1997
Comparative Study
. 1997 Apr 25;272(17):11295-301.
doi: 10.1074/jbc.272.17.11295.
Affiliations
- PMID: 9111034
- DOI: 10.1074/jbc.272.17.11295
Free article
Comparative Study
Identification of amino acids in the glutamate receptor, GluR3, important for antibody-binding and receptor-specific activation
N G Carlson et al. J Biol Chem. 1997.
Free article
Abstract
We reported (Twyman, R. E., Gahring, L. C., Speiss, J., and Rogers, S. W. (1995) Neuron 14, 755-762) that antibodies to a subregion of the glutamate receptor (GluR) subunit GluR3 termed GluR3B (amino acids 372-395), act as highly specific GluR agonists. In this study we produced additional rabbit anti-GluR3B-specific antibodies, ranked them according to their ability to function as GluR agonists and characterized the immunoreactivity using deletion and alanine substitution mutagenesis. These anti-GluR3B antibodies bound to a subset of the residues in GluR3B (amino acids 372-386), of which glutamate 375, valine 378, proline 379, and phenylalanine (Phe) 380 were preferred. The level of GluR activation correlated with the binding of antibody to Phe-380, which suggests that immunoreactivity directed toward Phe-380 is an index for the anti-GluR agonist potential. Since the identity of this residue varies between respective GluR subunits, this suggested that this residue may be important for imparting antibody subunit specificity. To test this possibility, the alanine in GluR1 was converted to a phenylalanine, which extended the subunit specificity from GluR3 to the modified GluR1. We conclude that antibody contacts with key residues in the GluR3B region define a novel GluR subunit-specific agonist binding site and impart subunit-specific immunoreactivity.
Similar articles
-
Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel.
Levite M, Fleidervish IA, Schwarz A, Pelled D, Futerman AH. Levite M, et al. J Autoimmun. 1999 Aug;13(1):61-72. doi: 10.1006/jaut.1999.0301. J Autoimmun. 1999. PMID: 10441169
-
Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site.
Twyman RE, Gahring LC, Spiess J, Rogers SW. Twyman RE, et al. Neuron. 1995 Apr;14(4):755-62. doi: 10.1016/0896-6273(95)90219-8. Neuron. 1995. PMID: 7718238
-
A model for a glutamate receptor agonist antibody-binding site.
McDonald S, Carlson NG, Gahring LC, Ely KR, Rogers SW. McDonald S, et al. J Mol Recognit. 1999 Jul-Aug;12(4):219-25. doi: 10.1002/(SICI)1099-1352(199907/08)12:4<219::AID-JMR457>3.0.CO;2-3. J Mol Recognit. 1999. PMID: 10440992
-
Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis?
Levite M, Hermelin A. Levite M, et al. J Autoimmun. 1999 Aug;13(1):73-82. doi: 10.1006/jaut.1999.0297. J Autoimmun. 1999. PMID: 10441170
-
Moga D, Hof PR, Vissavajjhala P, Moran TM, Morrison JH. Moga D, et al. J Chem Neuroanat. 2002 May;23(4):249-53. doi: 10.1016/s0891-0618(02)00012-1. J Chem Neuroanat. 2002. PMID: 12048108 Review.
Cited by
-
Lai Q, Li Q, Li X, Wang H, Zhang W, Song X, Hu P, Yao R, Fan H, Xu X. Lai Q, et al. Front Immunol. 2022 Apr 6;13:838389. doi: 10.3389/fimmu.2022.838389. eCollection 2022. Front Immunol. 2022. PMID: 35464426 Free PMC article.
-
Levite M. Levite M. J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1. J Neural Transm (Vienna). 2014. PMID: 25081016 Review.
-
Olivero G, Roggeri A, Pittaluga A. Olivero G, et al. Int J Mol Sci. 2023 Oct 5;24(19):14905. doi: 10.3390/ijms241914905. Int J Mol Sci. 2023. PMID: 37834353 Free PMC article. Review.
-
Cisani F, Olivero G, Usai C, Van Camp G, Maccari S, Morley-Fletcher S, Pittaluga AM. Cisani F, et al. Front Immunol. 2021 Feb 26;12:586521. doi: 10.3389/fimmu.2021.586521. eCollection 2021. Front Immunol. 2021. PMID: 33717067 Free PMC article.
-
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.
Hansen KB, Wollmuth LP, Bowie D, Furukawa H, Menniti FS, Sobolevsky AI, Swanson GT, Swanger SA, Greger IH, Nakagawa T, McBain CJ, Jayaraman V, Low CM, Dell'Acqua ML, Diamond JS, Camp CR, Perszyk RE, Yuan H, Traynelis SF. Hansen KB, et al. Pharmacol Rev. 2021 Oct;73(4):298-487. doi: 10.1124/pharmrev.120.000131. Pharmacol Rev. 2021. PMID: 34753794 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources